Clinical Trials Browser

Phase 3 × Neoplasm, Residual × 30 days × Clear all

NCT05232916 2026-03-19

FLAMINGO-01

Phase 3 Recruiting

Breast Neoplasms, Neoplasm, Residual

NCT07441291 2026-02-27

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Phase 3 Recruiting

Neoplasm, Residual